The first case of COVID-19 a coronavirus disease, was reported in December 2019 in
Wuhan, China, and spread globally. Severe acute respiratory syndrome coronavirus 2 …

With the relatively rapid development of the COVID-19 pandemic, vaccine development has
become crucial for limiting disease transmission. The accelerated growth in the approved …

RNA-based therapeutics have shown great promise in treating a broad spectrum of
diseases through various mechanisms including knockdown of pathological genes …

Adenoviral vectors have been explored as vaccine agents for a range of infectious diseases,
and their ability to induce a potent and balanced immune response made them logical …

Background The mainstay of control of the coronavirus disease 2019 (Covid-19) pandemic
is vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of
the coronavirus disease 2019 (COVID-19) pandemic, which has been a topic of major …

We report that there is a recent global expansion of numerous independent severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with mutation L452R in the …

The coronavirus is naturally mutating over time and producing new variants. Some of them
are more contagious and destructive than previous strains. Also, some variants are capable …

Dermatologists diagnose and treat many immune-mediated inflammatory diseases (IMID).
Understanding the inherent immune dysregulation of these diseases as well as the …

Background Due to the rapid spread of coronavirus disease 2019 (COVID-19) around the
world, the World Health Organization (WHO) declared it a global pandemic on March 11 …